Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Miller

Showing results (561-570 of 655) with videos related to

Pageof 66
Sort By:
Journal of the American Heart Association|December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United StatesWilliam S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Cancer Research|November 3, 2017
The ISB Cancer Genomics Cloud: A Flexible Cloud-Based Platform for Cancer Genomics ResearchSheila M Reynolds, Michael Miller, Phyliss Lee, et al.
Journal of the American Heart Association|February 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-ITBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
Journal of Clinical Lipidology|October 2, 2013
High-density lipoproteins: a consensus statement from the National Lipid AssociationPeter P Toth, Philip J Barter, Robert S Rosenson, et al.
Journal of Affective Disorders|July 11, 2017
Prediction of outcome of bright light treatment in patients with seasonal affective disorder: Discarding the early response, confirming a higher atypical balance, and uncovering a higher body mass index at baseline as predictors of endpoint outcomeTzvetelina D Dimitrova, Gloria M Reeves, Soren Snitker, et al.
The American Journal of Cardiology|April 14, 2012
Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendationsSeth S Martin, Thomas S Metkus, Aaron Horne, et al.
Stroke|March 7, 2020
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid HemorrhageAndrew P Carlson, Daniel Hänggi, George K Wong, et al.
Omics : a Journal of Integrative Biology|May 2, 2008
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?"Susanna-Assunta Sansone, Philippe Rocca-Serra, Marco Brandizi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 3, 2020
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final resultsBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
Journal of the American Chemical Society|December 22, 2023
Using a Function-First "Scout Fragment"-Based Approach to Develop Allosteric Covalent Inhibitors of Conformationally Dynamic Helicase MechanoenzymesJared R Ramsey, Patrick M M Shelton, Tyler K Heiss, et al.
Pageof 66

Showing results (561-570 of 655) with videos related to

Sort By:
Pageof 66
Journal of the American Heart Association|December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United StatesWilliam S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Cancer Research|November 3, 2017
The ISB Cancer Genomics Cloud: A Flexible Cloud-Based Platform for Cancer Genomics ResearchSheila M Reynolds, Michael Miller, Phyliss Lee, et al.
Journal of the American Heart Association|February 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-ITBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
Journal of Clinical Lipidology|October 2, 2013
High-density lipoproteins: a consensus statement from the National Lipid AssociationPeter P Toth, Philip J Barter, Robert S Rosenson, et al.
Journal of Affective Disorders|July 11, 2017
Prediction of outcome of bright light treatment in patients with seasonal affective disorder: Discarding the early response, confirming a higher atypical balance, and uncovering a higher body mass index at baseline as predictors of endpoint outcomeTzvetelina D Dimitrova, Gloria M Reeves, Soren Snitker, et al.
The American Journal of Cardiology|April 14, 2012
Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendationsSeth S Martin, Thomas S Metkus, Aaron Horne, et al.
Stroke|March 7, 2020
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid HemorrhageAndrew P Carlson, Daniel Hänggi, George K Wong, et al.
Omics : a Journal of Integrative Biology|May 2, 2008
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?"Susanna-Assunta Sansone, Philippe Rocca-Serra, Marco Brandizi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 3, 2020
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final resultsBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
Journal of the American Chemical Society|December 22, 2023
Using a Function-First "Scout Fragment"-Based Approach to Develop Allosteric Covalent Inhibitors of Conformationally Dynamic Helicase MechanoenzymesJared R Ramsey, Patrick M M Shelton, Tyler K Heiss, et al.
Pageof 66